Literature DB >> 6881330

Predominance of renal and absence of hepatic metabolism of pancreatic polypeptide in the dog.

W Hagopian, E G Lever, D Cohen, D Emmanouel, K S Polonsky, W Pugh, A Moossa, J B Jaspan.   

Abstract

Pancreatic polypeptide (PP) metabolism was studied in the dog. Metabolic clearance rate (MCR) of PP was found to be 9.5 +/- 0.9 ml . kg-1 . min-1, accounted for predominantly by renal extraction (34.9 +/- 2.6% of exogenous PP), which comprised 45.5 +/- 5.8% of total PP clearance. Hepatic extraction of both endogenous (-9.9 +/- 6.1%) and exogenous (2.2 +/- 1.4%) PP infused to pharmacological levels was negligible, as was its splanchnic extraction (4.2 +/- 0.9%). Renal organ clearance of exogenous PP (3.7 +/- 0.3 ml . kg-1 . min-1) closely approximated that of inulin (3.6 +/- 0.3 ml . kg-1 . min-1), indicating that renal PP metabolism occurs entirely by glomerular filtration without contribution from peritubular uptake mechanisms. Urinary PP, chromatographically indistinguishable from that in plasma but quantitatively accounting for less than 1% of overall renal PP uptake, indicated virtually complete renal degradation of the peptide to nonimmunoreactive fragments. Renal PP extraction was shown to be nonsaturable. Plasma half disappearance time of PP was 10.1 +/- 1.0 min and apparent distribution space 307 +/- 39 ml/kg. Linkage between the hepatic action and degradation of insulin and glucagon has been proposed, and in this light absent hepatic PP extraction is noteworthy. This finding, reminiscent of the hepatic handling of metabolically inert C-peptide and biologically inactive glucagon peptides, is consistent with the absence of demonstrable physiological function of PP.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6881330     DOI: 10.1152/ajpendo.1983.245.2.E171

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  13 in total

1.  Chronic estradiol and progesterone treatment in conscious dogs: effects on insulin sensitivity and response to hypoglycemia.

Authors:  Marcia R Batista; Marta S Smith; Wanda L Snead; Cynthia C Connolly; D Brooks Lacy; Mary Courtney Moore
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2005-06-16       Impact factor: 3.619

2.  Mechanisms of insulin resistance in experimental hyperinsulinemic dogs.

Authors:  P D Miles; S Li; M Hart; O Romeo; J Cheng; A Cohen; K Raafat; A R Moossa; J M Olefsky
Journal:  J Clin Invest       Date:  1998-01-01       Impact factor: 14.808

3.  Counterregulatory responses to hypoglycemia differ between glimepiride and glyburide in non diabetic individuals.

Authors:  Nino G Joy; Donna B Tate; Stephen N Davis
Journal:  Metabolism       Date:  2015-02-26       Impact factor: 8.694

4.  Effects of oral carbohydrate on autonomic nervous system counterregulatory responses during hyperinsulinemic hypoglycemia and euglycemia.

Authors:  Andrew C Ertl; Stephnie Mann; Antoinette Richardson; Vanessa J Briscoe; Hannah B Blair; Donna B Tate; Stephen N Davis
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-07-08       Impact factor: 4.310

5.  Hepatic glucagon metabolism. Correlation of hormone processing by isolated canine hepatocytes with glucagon metabolism in man and in the dog.

Authors:  W A Hagopian; H S Tager
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

6.  Acute Effects of Oral Dehydroepiandrosterone on Counterregulatory Responses During Repeated Hypoglycemia in Healthy Humans.

Authors:  Maia Mikeladze; Maka S Hedrington; Nino Joy; Donna B Tate; Lisa M Younk; Ian Davis; Stephen N Davis
Journal:  Diabetes       Date:  2016-08-02       Impact factor: 9.461

7.  Effects of differing antecedent increases of plasma cortisol on counterregulatory responses during subsequent exercise in type 1 diabetes.

Authors:  Shichun Bao; Vanessa J Briscoe; Donna B Tate; Stephen N Davis
Journal:  Diabetes       Date:  2009-06-09       Impact factor: 9.461

8.  Effects of antecedent GABAA activation with alprazolam on counterregulatory responses to hypoglycemia in healthy humans.

Authors:  Maka S Hedrington; Stephnie Farmerie; Andrew C Ertl; Zhihui Wang; Donna B Tate; Stephen N Davis
Journal:  Diabetes       Date:  2010-01-19       Impact factor: 9.461

9.  Effects of the selective serotonin reuptake inhibitor fluoxetine on counterregulatory responses to hypoglycemia in individuals with type 1 diabetes.

Authors:  Vanessa J Briscoe; Andrew C Ertl; Donna B Tate; Stephen N Davis
Journal:  Diabetes       Date:  2008-10-03       Impact factor: 9.461

10.  Effects of intensive therapy and antecedent hypoglycemia on counterregulatory responses to hypoglycemia in type 2 diabetes.

Authors:  Stephen N Davis; Stephanie Mann; Vanessa J Briscoe; Andrew C Ertl; Donna B Tate
Journal:  Diabetes       Date:  2008-12-10       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.